RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Case report: sudden death following the administration of CAR-NK cells for lung cancer immunotherapy.
Case report: sudden death following the administration of CAR-NK cells for lung cancer immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肺癌是一种高度恶性的肿瘤。尽管手术、放疗和化疗已取得重大进展并成为临床治疗的常规方法,但总体生存率仍然较低。近年来,靶向治疗和免疫治疗在肿瘤临床治疗中发展迅速。其中,自然杀伤(NK)细胞具有快速杀伤病变细胞和移植物抗宿主反应风险低的优势,被认为是嵌合抗原受体(CAR)的良好载体,使其在肿瘤免疫治疗中具有良好的应用前景。然而,其在肺癌中的临床应用仍需进一步研究。在此,我们报告了一例肺癌患者切除术后接受CAR-NK细胞免疫治疗,在第四次治疗后引起细胞因子风暴并猝死的病例。本病例报告为免疫治疗后死亡尸体的法医学检验提供了参考,并对细胞免疫治疗的临床应用提出了挑战。
Lung cancer is a high degree of malignancy. Although surgery, radiotherapy, and chemotherapy have made significant progress and become general methods of clinical treatment, the overall survival rate is still low. In recent years, targeted therapy and immunotherapy have a rapid development in the clinical treatment of tumors.
Among them, natural killer (NK) cells have the advantages of rapid killing of diseased cells and low risk of graft-versus-host reaction. It is considered a great vector for chimeric antigen receptors (CARs), making them have good application prospects in tumor immunotherapy.
However, its clinical application in lung cancer needs further research.
Herein, we reported a case of a lung cancer patient undergoing CAR-NK cell immunotherapy after resection, which caused a cytokine storm and sudden death after the fourth treatment. This case report provides a reference for the forensic examination of cadavers that died after immunotherapy and challenges the clinical application of cell immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。